Slides: SGLT2 inhibition in cardiology: What is the profile of benefit? - PACE-CME
ESC 365 - State of the Art - SGLT2 inhibitors in cardiovascular disease
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications - The Lancet
ESC 365 - Everything you need to know about SGLT2 inhibitors in heart failure – discussion.
JCM | Free Full-Text | SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure—A Concise Review
ESC 365 - SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?
Glucose-lowering therapy in patients undergoing percutaneous coronary intervention - EuroIntervention
The latest ESC guidelines for glucose lowering agents and CVD -SGLT2i... | Download Scientific Diagram
EASD/ESC Symposium: Cardiorenal protection with SGLT2 inhibitors: A benefit for all and also outside diabetes? - Media Centre | EASD
Nuove linee guida europee sull'insufficienza cardiaca: SGLT2 inibi
Nuove linee guida europee sull'insufficienza cardiaca: SGLT2 inibi
SGLT2 inhibitor reduces CV death and worsening HF events in HFrEF patients - PACE-CME
European Society of Cardiology on Twitter: "Which patients should be prioritised for treatment with sacubitril/valsartan? SGLT2 inhibitors -a new class of diuretic? Test yourself & discover what's new in the ESC #HFA
Hot Line - SGLT2 inhibitors deliver in patients with preserved and mildly reduced ejection fraction
ESC 365 - Everything you need to know about SGLT2 inhibitors in heart failure – discussion.
Pharmaceutics | Free Full-Text | The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective
DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum | tctmd.com
SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects | Journal of the American Heart Association
JCM | Free Full-Text | SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure—A Concise Review
2021 ESC guideline on Heart Failure: SGLT2 inhibitors finally entering the centre stage and more.
ESC 365 - SGLT2 inhibitors and heart failure: expensive diuretics or added value?
Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week - ScienceDirect
